Literature DB >> 9404750

The effect of a peak flow-based action plan in the prevention of exacerbations of asthma.

R L Cowie1, S G Revitt, M F Underwood, S K Field.   

Abstract

STUDY
OBJECTIVE: To determine the effect of a symptom-based and a peak flow-based action plan in preventing acute exacerbations in subjects with poorly controlled asthma.
DESIGN: A randomized controlled trial in which subjects who had required urgent treatment for their asthma were allocated to receive no action plan, a symptom-based plan, or a peak flow-based action plan.
SETTING: A university hospital asthma clinic. POPULATION: One hundred fifty subjects were recruited after attending an emergency department or a clinic for urgent treatment of asthma.
INTERVENTIONS: All subjects received evaluation and education for asthma before being randomly allocated to receive no action plan, a symptom-based action plan, or a peak flowmeter and a peak flow-based action plan. MEASUREMENTS: Subjects were assessed by questionnaire at 3 and 6 months after enrollment with questions relating to their asthma control and their need for urgent treatment or hospital admission for asthma.
RESULTS: At 6 months after enrollment, although all three intervention groups experienced improvement in their asthma control, there was a striking reduction in emergency department visits for asthma only in the peak flow-based action plan group (p=0.006). No significant difference in emergency visits was apparent between the symptom-based action plan and no action plan groups.
CONCLUSIONS: We conclude that a peak flow-based action plan is effective, at least in the short term, in protecting patients with asthma against severe exacerbations of their disease.

Entities:  

Mesh:

Year:  1997        PMID: 9404750     DOI: 10.1378/chest.112.6.1534

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

Review 1.  Severe acute asthma.

Authors:  S Salmeron; M Bard; F X Blanc; A Ellrodt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Personalized action plans. How to help your patients manage their asthma.

Authors:  Alan Kaplan
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

3.  A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma.

Authors:  A Sonia Buist; William M Vollmer; Sandra R Wilson; E Ann Frazier; Arthur D Hayward
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

Review 4.  Asthma exacerbations . 4: Prevention.

Authors:  J M FitzGerald; P G Gibson
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 5.  Interventions for educating children who are at risk of asthma-related emergency department attendance.

Authors:  Michelle Boyd; Toby J Lasserson; Michael C McKean; Peter G Gibson; Francine M Ducharme; Michelle Haby
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 6.  Management of acute asthma in adults in the emergency department: nonventilatory management.

Authors:  Rick Hodder; M Diane Lougheed; Brian H Rowe; J Mark FitzGerald; Alan G Kaplan; R Andrew McIvor
Journal:  CMAJ       Date:  2009-10-26       Impact factor: 8.262

7.  Peak flow meters for asthma patients. Do they up the benefits or up the costs?

Authors:  C P Por; M F Evans
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

Review 8.  Recent changes: pulmonary medicine.

Authors:  N Roche
Journal:  BMJ       Date:  1999-01-16

9.  Audit of acute asthma management at the Paediatric Emergency Department at Wad Madani Children's Hospital, Sudan.

Authors:  Salma M H Ibrahim; Huda M Haroun; Hassan M Ali; Imad Eldeen M Tag Eldeen
Journal:  Sudan J Paediatr       Date:  2012

10.  Action plans in patients presenting to emergency departments with asthma exacerbations: Frequency of use and description of contents.

Authors:  Elfriede Cross; Cristina Villa-Roel; Sumit R Majumdar; Mohit Bhutani; Rhonda J Rosychuk; Stephanie Couperthwaite; Brian H Rowe
Journal:  Can Respir J       Date:  2014 November/December       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.